Conneqt Health Limited (CQT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Conneqt Health Limited (CQT) has a cash flow conversion efficiency ratio of 1.844x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$-2.46 Million ≈ $-1.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Conneqt Health Limited (CQT) balance sheet quality index to measure how much of total assets are equity-financed.
Conneqt Health Limited - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Conneqt Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore CQT long-term investments to assets to see how much of total assets are deployed in long-term investments.
Conneqt Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Conneqt Health Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RUGBY RESOURCES LTD
F:64O
|
N/A |
|
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
|
N/A |
|
Danish Aerospace Company A/S
CO:DAC
|
0.428x |
|
Radiant Utama Interinsco Tbk
JK:RUIS
|
0.008x |
|
East Asia Holdings Investment Limited
KQ:900110
|
0.031x |
|
Gaya Abadi Sempurna
JK:SLIS
|
-0.002x |
|
Orex Minerals Inc
V:REX
|
-0.271x |
|
PHOENIX NEW MED.ADR 1/48
F:1PX
|
N/A |
Annual Cash Flow Conversion Efficiency for Conneqt Health Limited (2023–2025)
The table below shows the annual cash flow conversion efficiency of Conneqt Health Limited from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Conneqt Health Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$633.50K ≈ $448.24K |
AU$-10.90 Million ≈ $-7.71 Million |
-17.200x | -810.51% |
| 2024-06-30 | AU$4.09 Million ≈ $2.89 Million |
AU$-7.72 Million ≈ $-5.46 Million |
-1.889x | -111.79% |
| 2023-06-30 | AU$-748.40K ≈ $-529.54K |
AU$-12.00 Million ≈ $-8.49 Million |
16.029x | -- |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more